-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*For medical professionals only
▎ Clinical Problems:
It is unclear
how prolonged time for perioperative use of low molecular weight heparin for thromboprophylaxis will have a disease-free survival (DFS) after surgical resection of colorectal cancer.
1 minute a day, give you a professional "talking point" in the tumor circle! (If you need the original text of the literature, you can add the small editor WeChat yxj_oncology to get)
1
BMJ: Prolonged perioperative use of low-molecular-weight heparin for thromboprophylaxis does not improve disease-free or overall survival in patients with colorectal cancer who undergo surgical resection
▎ Clinical Problems:
It is unclear
how prolonged time for perioperative use of low molecular weight heparin for thromboprophylaxis will have a disease-free survival (DFS) after surgical resection of colorectal cancer.
4.
Follow the column
Subscribe to the column and read a new top issue every day!
Download the Doctor Station App and subscribe anytime, anywhere